Trial Profile
PG2 Injection 500 mg in Acute Stroke Study (Pass): A Randomized, Double-Blind, Placebo-Controlled Study of PG2 Injection 500 mg in Patients With Treatment Started Within 3-6 Hrs of the Onset of Acute Ischemic Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2017
Price :
$35
*
At a glance
- Drugs PG 2 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms Pass
- 25 Sep 2017 New trial record